Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quoted. Dec 14, 2017. JC Scott.

Executive Summary

Check out what top AdvaMed lobbyist JC Scott has to say about the  effort to fit an extended five-year moratorium on the device excise tax into Congress' end-of-year rush.

"From what I've heard from our companies, and it's a little different for each of them, it's really untenable to work around one or two years. As you think about the timeframes they have to work around, that's when you land in the neighborhood of five years." – JC Scott, chief advocacy officer and head of external affairs, AdvaMed

> Find out more: In Last Ditch Effort, Lawmakers Propose Five-Year Device Tax Moratorium

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121915

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel